Oxford PharmaGenesis munch on lunch
The recent ‘Health and Wellbeing’ lunch for all staff in the Oxford office highlighted the various ways in which the company supports employee wellbeing.
19 June 2025
Over the past two months, we’ve had the privilege of engaging with the healthcare communications and patient engagement communities at MAPS EMEA, ISMPP Annual, ISPOR US and Patients as Partners Europe. Across continents and conversations, one theme clearly stood out: patient involvement is no longer optional – it is essential.
The recent ‘Health and Wellbeing’ lunch for all staff in the Oxford office highlighted the various ways in which the company supports employee wellbeing.
We are thrilled to congratulate Andy Sheridan on his 10th anniversary at Oxford PharmaGenesis. Andy already had a distinguished record in medical communications when he joined the company, and quickly made his mark by helping us to win our first project with Shire when we were about a fifth of our current size. Now one…
Blessed with near-perfect weather conditions for cycling (dry and warm, with very little wind), Oxford PharmaGenesis Commercial Director, Richard White, completed the British Heart Foundation’s Oxford to Cambridge bike ride in a time of 5 hours and 45 minutes on Saturday 27 September. “This was a superbly organized event and I felt very proud to…
Primary care physicians use a range of approaches to manage irritable bowel syndrome (IBS) in primary care, reports a systematic review co-authored by the Rome Foundation and researchers from Oxford PharmaGenesis. The article, which appeared online in Alimentary Pharmacology & Therapeutics this month, shows that primary care physicians are often comfortable diagnosing and managing IBS…
On Friday 19 September 2014 a bunch of friendly Oxford PharmaGenesis faces made the journey to London to attend The Naturejobs Career Expo 2014, which was held at the Business Design Centre. It was a very successful event and the team met some fantastic candidates.
Dr Jonathan Morton, Communications Director of our Rare and Orphan Diseases Practice, will be speaking at the World Orphan Drug Congress in November. In the interview below, he provides an insight into the upcoming panel discussion at this congress, as well what he hopes to achieve in order to improve standards of care for patients…